MENU
CTOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Citius Oncology (CTOR) Earnings Date & Reports
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies... Show more
A.I. Advisor
published Earnings
CTOR is expected to report earnings to rise 137.50% to -18 cents per share on December 17
Q3'26
Est.
$-0.19
Q2'26
Missed
by $0.08
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
The last earnings report on August 14 showed earnings per share of -7 cents, missing the estimate of 0 cents. With 131.77K shares outstanding, the current market capitalization sits at 108.93M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Industry
N/A
Address
11 Commerce Drive
Phone
+1 908 967-6677
Employees
N/A
Web
https://www.citiusonc.com